Abstract: A laparoscopic image smoke removal method based on a generative adversarial network, and belongs to the technical field of computer vision. The method includes: processing a laparoscopic image sample to be processed using a smoke mask segmentation network to acquire a smoke mask image; inputting the laparoscopic image sample to be processed and the smoke mask image into a smoke removal network, and extracting features of the laparoscopic image sample to be processed using a multi-level smoke feature extractor to acquire a light smoke feature vector and a heavy smoke feature vector; and acquiring, according to the light smoke feature vector, the heavy smoke feature vector and the smoke mask image, a smoke-free laparoscopic image by filtering out smoke information and maintaining a laparoscopic image by using a mask shielding effect. The method has the technical effects of robustness and ability of being embedded into a laparoscopic device for use.

Abstract: A diode and a manufacturing method therefor, and a semiconductor device. The diode includes: a substrate; an insulating buried layer provided on the substrate; a semiconductor layer provided on the insulating buried layer; anode; and a cathode, comprising: a trench-type contact, a trench being filled with a contact material, the trench extending from a first surface of the semiconductor layer to a second surface of the semiconductor layer, the first surface being a surface distant from the insulating buried layer, and the second surface being a surface facing the insulating buried layer; a cathode doped region surrounding the trench-type contact around and at the bottom of the trench-type contact, and also disposed on the first surface around the trench-type contact; and a negative electrode located on the cathode doped region and electrically connected to the cathode doped region.

Abstract: A display panel, a manufacturing method thereof, and a display device are provided. The display panel includes a first display substrate, a second display substrate, and a third display substrate; the second display substrate and the first display substrate are assembled to form a first liquid crystal cell; the third display substrate and the second display substrate are assembled to form a second liquid crystal cell; the display panel further includes a first wire grid polarizer on the second display substrate and a first bonding portion at a side of the second display substrate close to the first display substrate, and the first bonding portion is located outside the first liquid crystal cell; and an orthographic projection of the first wire grid polarizer on the second display substrate is not overlapped with an orthographic projection of the first bonding portion on the second display substrate.

Abstract: Fusing nanowire inks are described that can also comprise a hydrophilic polymer binder, such as a cellulose based binder. The fusing nanowire inks can be deposited onto a substrate surface and dried to drive the fusing process. Transparent conductive films can be formed with desirable properties.

Abstract: Disclosed herein are aqueous pharmaceutical formulations comprising denosumab or another human anti-RANKL monoclonal antibody or portion thereof, and characteristics of pH, buffer systems, and amino acid aggregation inhibitors. Also disclosed are presentation of the formulation for use, e.g. in a single-use vial, single-use syringe, or glass container, methods of using the formulations and articles for preventing or treating diseases, and related kits.

Abstract: Fusing nanowire inks are described that can also comprise a hydrophilic polymer binder, such as a cellulose based binder. The fusing nanowire inks can be deposited onto a substrate surface and dried to drive the fusing process. Transparent conductive films can be formed with desirable properties.

Abstract: This disclosure is directed to a pharmaceutical composition comprises tumor inhibiting cells (TICs) and a method for producing the TICs. The tumor inhibiting cells can be derived from immune cells including T cells, NK cells, or a combination thereof, modified to have inactivated Cbl-b gene alleles and free from Cbl-b bio-function (Cbl-b?/? TICs). The Cbl-b?/? TICs are free from deoxyribonucleic acids exogenous to the immune cells. The immune cells can be isolated using a portable cell isolation and modification device. This disclosure is further directed to a method for treating tumorous conditions in subjects. The pharmaceutical composition can provide a subject-specific tumor treatment.

Abstract: Disclosed herein is a holographic mixture including nanoparticles used to form gratings through holographic exposure. In various embodiments, exposure of the holographic mixture causes the nanoparticles to diffuse to dark fringe regions which creates nanoparticle rich regions and nanoparticle poor regions. Some embodiments include a multi-layer grating which includes a layer formed through the exposed holographic mixture and another layer directly applied above the exposed holographic mixture. The other layer may also be exposed through a holographic recording beam.

Abstract: Fusing nanowire inks are described that can also comprise a hydrophilic polymer binder, such as a cellulose based binder. The fusing nanowire inks can be deposited onto a substrate surface and dried to drive the fusing process. Transparent conductive films can be formed with desirable properties.

Abstract: Fusing nanowire inks are described that can also comprise a hydrophilic polymer binder, such as a cellulose based binder. The fusing nanowire inks can be deposited onto a substrate surface and dried to drive the fusing process. Transparent conductive films can be formed with desirable properties.

Abstract: Disclosed herein are aqueous pharmaceutical formulations comprising denosumab or another human anti-RANKL monoclonal antibody or portion thereof, and characteristics of pH, buffer systems, and amino acid aggregation inhibitors. Also disclosed are presentation of the formulation for use, e.g. in a single-use vial, single-use syringe, or glass container, methods of using the formulations and articles for preventing or treating diseases, and related kits.

Abstract: A backlight module and a display module are provided. The backlight module includes a back plate, a light guide plate, and a light source. The back plate includes a receiving cavity. One side of the back plate is formed with a through hole. The light guide plate is disposed in the receiving cavity. A light incident surface of the light guide plate corresponds to the through hole, the light source is disposed in the through hole, and the light source corresponds to the light incident surface of the light guide plate. By forming the through hole on one side of the back plate and providing the light source in the through hole, a side frame is not required to be provided, a thickness of a frame of the backlight module is reduced, and a narrow frame is realized.

Abstract: A backlight module and a display module are provided. The backlight module includes a back plate, a light guide plate, and a light source. The back plate includes a receiving cavity. One side of the back plate is formed with a through hole. The light guide plate is disposed in the receiving cavity. A light incident surface of the light guide plate corresponds to the through hole, the light source is disposed in the through hole, and the light source corresponds to the light incident surface of the light guide plate. By forming the through hole on one side of the back plate and providing the light source in the through hole, a side frame is not required to be provided, a thickness of a frame of the backlight module is reduced, and a narrow frame is realized.

Abstract: Disclosed herein are aqueous pharmaceutical formulations comprising denosumab or another human anti-RANKL monoclonal antibody or portion thereof, and characteristics of pH, buffer systems, and amino acid aggregation inhibitors. Also disclosed are presentation of the formulation for use, e.g. in a single-use vial, single-use syringe, or glass container, methods of using the formulations and articles for preventing or treating diseases, and related kits.

Abstract: Nanoscale colorants are introduced to adjust the hue of transparent conductive films, such as to provide a whiter film. The transparent conductive films can have sparse metal conductive layers, which can be formed using silver nanowires. Color of the film can be evaluated using standard color parameters. In particular, values of color parameter b* can be reduced with the nanoscale colorants without unacceptably changing other parameters, such as haze, a* and transparency.

Abstract: Nanoscale colorants are introduced to adjust the hue of transparent conductive films, such as to provide a whiter film. The transparent conductive films can have sparse metal conductive layers, which can be formed using silver nanowires. Color of the film can be evaluated using standard color parameters. In particular, values of color parameter b* can be reduced with the nanoscale colorants without unacceptably changing other parameters, such as haze, a* and transparency.

Abstract: Fusing nanowire inks are described that can also comprise a hydrophilic polymer binder, such as a cellulose based binder. The fusing nanowire inks can be deposited onto a substrate surface and dried to drive the fusing process. Transparent conductive films can be formed with desirable properties.

Abstract: An oscillatory power tool that is capable of using various types of cutting tools is disclosed. The power tool includes an output shaft for mounting one of the cutting tools and driving the cutting tool in an oscillating rotary motion. An end of the output shaft has a driving section for engaging with a securing section of the cutting tool. The power tool further includes a fastener connected to the output shaft at the end and connectable to the securing section of the cutting tool for fastening the cutting tool to the end of the output shaft. The driving section has a fitting surface for contacting a surface of the securing section. Through a close fit between the friction surface and the surface of the securing section, the power tool can be connected with different types of cutting tools, which greatly improves the universality and convenience of the power tool.

Abstract: A backlight module and a display device are provided. A light reflection layer is disposed at a backlight side of a through-hole region. And the light reflection layer is disposed at an inner side of an iron frame. After a reflection surface (i.e., a first light-reflecting region) receiving light from a backlight source, the light is reflected to the backlight side of the through-hole to brighten the backlight side. The first light-reflecting region enables a relatively dark area of the backlight side to obtain stronger reflection light, and enables a relatively bright area of the backlight side to obtain weaker reflection light, so that a brightness is uniformly distributed after the backlight side being brightened, thereby achieving a brightening effect.

Abstract: Fusing nanowire inks are described that can also comprise a hydrophilic polymer binder, such as a cellulose based binder. The fusing nanowire inks can be deposited onto a substrate surface and dried to drive the fusing process. Transparent conductive films can be formed with desirable properties.